Weiss Asset Management’s NRX Pharmaceuticals NRXP Stock Holding History

Weiss Asset Management’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8,267	Closed	-$876K	–	289
2019 Q4	$876K	Sell	8,267 -16,177	-66%	-$1.71M	0.06%	115
2019 Q3	$2.59M	Sell	24,444 -33,887	-58%	-$3.55M	0.21%	70
2019 Q2	$6.13M	Buy	58,331 +31,190	+115%	+$3.24M	0.37%	52
2019 Q1	$2.8M	Buy	27,141 +24,400	+890%	+$2.51M	0.22%	84
2018 Q4	$280K	Buy	+2,741	New	+$277K	0.02%	283
2018 Q2	–	Sell	-38,140	Closed	-$3.75M	–	253
2018 Q1	$3.75M	Buy	38,140 +20,560	+117%	+$2M	0.3%	57
2017 Q4	$1.7M	Buy	+17,580	New	+$1.7M	0.15%	73

Other funds holding NRXP

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.47% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BCM

Bluefin Capital Management New York $156M AUM 18.42% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Weiss Asset Management's NRXP Position: Q1 2020 in Review

Weiss Asset Management sold out of NRX Pharmaceuticals (NRXP) in Q1 2020, closing a stake of 8,267 shares — an estimated $876K sold.

Weiss Asset Management first reported a position in NRXP in Q4 2017 and held it in 7 quarters. The position peaked at $6.13M in Q2 2019. 7 funds tracked by Wall St. Rank hold NRXP as of Q1 2020.

Weiss Asset Management reported no remaining NRX Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Weiss Asset Management sold 8,267 NRX Pharmaceuticals shares in Q1 2020, an estimated $876K.
Weiss Asset Management first reported a position in NRX Pharmaceuticals in Q4 2017 and held it in 7 quarters.
Weiss Asset Management's NRX Pharmaceuticals position peaked at $6.13M in Q2 2019.
7 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q1 2020.

Based on Weiss Asset Management's 13F filing for Q1 2020, filed 14 May 2020.